История инсулина – история надежды
Аникин Г.С., Стожкова И.В. История инсулина – история надежды. FOCUS Эндокринология. 2021; 3: 48–51. DOI: 10.47407/ef2021.2.3.0034
Anikin GS, Stozhkova IV. History of insulins, history of hope. FOCUS Endocrinology. 2021; 3: 48–51. DOI: 10.47407/ef2021. 2.3.0034
Инсулинотерапия зачастую составляет основу лечения сахарного диабета. Открытие инсулина дало надежду многим пациентам с данной патологией, но до этого человечество прошло длинный и тернистый путь. Об этом пути мы и хотели бы рассказать в нашей статье.
Ключевые слова: сахарный диабет, инсулин, эндокринология.
Ключевые слова: сахарный диабет, инсулин, эндокринология.
1. Colwell AR. The Banting Memorial Lecture 1968: Fifty Years of Diabetes in Per-spective. Diabete 1968; 17 (10): 599–610. DOI: 10.2337/diab.17.10.599
2. Костяков С.Е., Демяненко А.Н. Исторические предпосылки открытия инсулина. Вестник Смоленской государственной медицинской акаде-мии. 2013; 12 (3): 90–7.
[Kostiakov S.E., Demianenko A.N. Istoricheskie predposylki otkrytiia insulina. Vestnik Smolenskoi gosudarstvennoi meditsinskoi akademii. 2013; 12 (3): 90–7 (in Russian)].
3. Vecchio I, Tornali C, Bragazzi NL, Martini M. The Discovery of Insulin: An Im-portant Milestone in the History of Medicine. Front Endocrinol 2018; 9: 1–8. DOI: 10.3389/fendo.2018.00613
4. Сорокина Л.А. У истоков открытия инсулина. Артериальная гипертен-зия. 2010; 5: 26–8.
[Sorokina L.A. U istokov otkrytiia insulina. Arterial'naia gipertenziia. 2010; 5: 26–8 (in Russian)].
5. Karamitsos DT. The story of insulin discovery. Diabet Res Clin Pract 2011; 93: S2–S8. DOI: 10.1016/s0168-8227(11)70007-9
6. Bliss M. The Discovery of Insulin. Chicago: The University of Chicago Press, 1982.
7. Lapolla A, Dalfrà MG. Hundred Years of Insulin Therapy. Am J Therapeut 2020; 27 (1): e24–e29. DOI: 10.1097/mjt.0000000000001081
8. Kung K, Do Y, Huang W. Total synthesis of cristalline insulin. Scientia Sinica 1966; 15: 544–61.
9. Howey DC, Bowsher RR, Brunelle RL et al. Lispro [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396–2.
10. Simpson KL, Spencer CM. Insulin aspart. Drugs 1999; 57: 759–65.
11. Barlocco D. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances. Curr Opin Investig Drugs 2003; 4: 1240–4.
12. Fala L. Afrezza (insulin human) inhalation powder approved for the treatment of patients with type 1 or type 2 diabetes. Am Health Drug Benefits 2015; 8: 40–3.
13. Modi P, Mihic M, Lewin A. The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist system. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S38–42. DOI: 10.1002/dmrr.208
2. Костяков С.Е., Демяненко А.Н. Исторические предпосылки открытия инсулина. Вестник Смоленской государственной медицинской акаде-мии. 2013; 12 (3): 90–7.
[Kostiakov S.E., Demianenko A.N. Istoricheskie predposylki otkrytiia insulina. Vestnik Smolenskoi gosudarstvennoi meditsinskoi akademii. 2013; 12 (3): 90–7 (in Russian)].
3. Vecchio I, Tornali C, Bragazzi NL, Martini M. The Discovery of Insulin: An Im-portant Milestone in the History of Medicine. Front Endocrinol 2018; 9: 1–8. DOI: 10.3389/fendo.2018.00613
4. Сорокина Л.А. У истоков открытия инсулина. Артериальная гипертен-зия. 2010; 5: 26–8.
[Sorokina L.A. U istokov otkrytiia insulina. Arterial'naia gipertenziia. 2010; 5: 26–8 (in Russian)].
5. Karamitsos DT. The story of insulin discovery. Diabet Res Clin Pract 2011; 93: S2–S8. DOI: 10.1016/s0168-8227(11)70007-9
6. Bliss M. The Discovery of Insulin. Chicago: The University of Chicago Press, 1982.
7. Lapolla A, Dalfrà MG. Hundred Years of Insulin Therapy. Am J Therapeut 2020; 27 (1): e24–e29. DOI: 10.1097/mjt.0000000000001081
8. Kung K, Do Y, Huang W. Total synthesis of cristalline insulin. Scientia Sinica 1966; 15: 544–61.
9. Howey DC, Bowsher RR, Brunelle RL et al. Lispro [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396–2.
10. Simpson KL, Spencer CM. Insulin aspart. Drugs 1999; 57: 759–65.
11. Barlocco D. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances. Curr Opin Investig Drugs 2003; 4: 1240–4.
12. Fala L. Afrezza (insulin human) inhalation powder approved for the treatment of patients with type 1 or type 2 diabetes. Am Health Drug Benefits 2015; 8: 40–3.
13. Modi P, Mihic M, Lewin A. The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist system. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S38–42. DOI: 10.1002/dmrr.208